Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosus.
Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosus.
复制标题
霉酚酸酯成功治疗与系统性红斑狼疮相关的亚急性进行性间质性肺病。
DOI：
10.1080/24725625.2020.1774974
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Fujio K.
中科院分区：
文献类型：
--
作者：
Hanata N;Shoda H;Fujio K.
症状性间质性肺疾病（ILD）在系统性红斑狼疮（SLE）中很少见，目前还没有确定的治疗方法。我们报告一例SLE患者发生亚急性进行性ILD，并经吗替麦考酚酯治疗成功。吗替麦考酚酯可能是SLE相关ILD的一种有前途的治疗选择。
Symptomatic interstitial lung disease (ILD) is rare in systemic lupus erythematosus (SLE), and there is no established treatment for it. We report a case of subacute progressive ILD in a patient with SLE, which was successfully treated by mycophenolate mofetil. Mycophenolate mofetil may be a promising therapeutic choice for SLE-associated ILD.